Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00720486 · ClinicalTrials.gov registry record · NA

Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders

A NA study of Anger, sponsored by naomi goldstein.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT00720486 is a NA study of Anger that has completed, run by naomi goldstein. The registered enrollment target is 75 participants, roughly in line with the 75-participant average among 10 other Anger trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00720486, a NA study of Anger, has completed, sponsored by naomi goldstein.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.

Conditions Studied

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Juvenile Justice Anger Management (JJAM) for Girls

Study Locations (1)

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2008-06
Est. Completion 2012-02
Phase NA

Sponsor

naomi goldstein

1 total trials

What the Registry Record Tells You About NCT00720486

The ClinicalTrials.gov registry entry for NCT00720486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 75-participant average among 10 other Anger trials with a reported enrollment target. The listed sponsor is naomi goldstein, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anger appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT00720486 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00720486 about?

NCT00720486 is a clinical study titled "Effectiveness of Anger Management Treatment in Reducing Anger-Related Behaviors in Female Juvenile Offenders". This study will evaluate the effectiveness of an anger management treatment program, Juvenile Justice Anger Management for Girls, in reducing anger-related behaviors displayed by girls in the juvenile justice system.

What is the current status of trial NCT00720486?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2008-06. Estimated completion is 2012-02.

What conditions does trial NCT00720486 study?

This clinical trial studies the following conditions: Anger.

What interventions are being tested in trial NCT00720486?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Juvenile Justice Anger Management (JJAM) for Girls (BEHAVIORAL).

Who is sponsoring clinical trial NCT00720486?

This trial is sponsored by naomi goldstein, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00720486 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.